DJSI Recognizes Our Commitment to Society
We have been awarded the second highest score in the pharma industry by the Dow Jones Sustainability Index (DJSI) for the 15th consecutive year
Our commitment to fight COVID-19
Throughout the ongoing pandemic, Sanofi has joined forces to fight COVID-19 in every way possible
mRNA Technology: Vaccines and Beyond
mRNA science has given our R&D teams more ways to develop vaccines against different infectious diseases, and to keep pace with emerging health threats
Sanofi’s Rare Humanitarian Program Turns 30
“Our purpose is clear–to help ensure that people living with rare diseases around the world have the ability to access the treatments they need” -Paul Hudson, Chief Executive Officer
Join us!
You will join a diverse mix of people, who genuinely believe in our mission to help people around the world live healthier lives
-
Press releases2022-01-19MMMM DD YYYYSecond positive Phase 3 Dupixent® (dupilumab) trial confirms significant improvements for patients with prurigo nodularis